A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients

• Marita Ziepert,
• Stefano Lazzi,
• Raffaella Santi,
• Federica Vergoni,
• Massimo Granai,
• Virginia Mancini,
• Annette Staiger,
• Heike Horn,
• Markus Löffler,
• Viola Pöschel,
• Gerhald Held,
• Gerald Wulf,
• Lorenz H. Trümper,
• Norbert Schmitz,
• Andreas Rosenwald,
• Elena Sabattini,
• Kikkeri N. Naresh,
• Harald Stein,
• German Ott,
• Lorenzo Leoncini

Affiliations

Marita Ziepert

Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany;

Stefano Lazzi

Department of Medical Biotechnology, Section of Pathology, University of Siena, Siena, Italy;

Raffaella Santi

Department of Pathology, Careggi University Hospital, University of Firenze, Firenze, Italy;

Federica Vergoni

Department of Pathology, Careggi University Hospital, University of Firenze, Firenze, Italy;

Massimo Granai

Department of Medical Biotechnology, Section of Pathology, University of Siena, Siena, Italy;

Virginia Mancini

Department of Medical Biotechnology, Section of Pathology, University of Siena, Siena, Italy;

Annette Staiger

Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany;

Heike Horn

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany;

Markus Löffler

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany;

Viola Pöschel

DSHNHL Studiensekretariat, Universitätsklinikum des Saarlandes, Homburg, Germany;

Gerhald Held

DSHNHL Studiensekretariat, Universitätsklinikum des Saarlandes, Homburg, Germany;

Gerald Wulf

Department of Hematology and Oncology, Georg-August Universität, Göttingen, Germany;

Lorenz H. Trümper

Göttingen Comprehensive Cancer Center, University Medicine Göttingen, Germany;

Norbert Schmitz

Department of Medicine A, University Hospital Münster, Münster, Germany;

Andreas Rosenwald

Institute of Pathology, Universitat Würzburg, Comprehensive Cancer Center Mainfranken, Germany;

Elena Sabattini

Institute of Hematology "L. and A. Seràgnoli", S. Orsola - Malpighi Hospital, Bologna, Italy;

Kikkeri N. Naresh

Hammersmith Hospital and Imperial College, London, UK;

Harald Stein

Pathodiagnostik Berlin, Berlin, Germany

German Ott

Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany;

Lorenzo Leoncini

Department of Medical Biotechnology, Section of Pathology, University of Siena, Siena, Italy;